Evidence map›Paper›PMID 34832945›Full record

ArticlePharmaceuticals (Basel, Switzerland)2021

Polyhydroxybutyrate-Based Nanocomposites for Bone Tissue Engineering.

Anand Mohan, Madhuri Girdhar, Raj Kumar, Harshil S Chaturvedi, Agrataben Vadhel, Pratima R Solanki, Anil Kumar, Deepak Kumar, Narsimha Mamidi

Open access · goldAbstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 55 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. 3D Printed Piezoelectric BaTiOBioengineering (Basel, Switzerland) · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Anand MohanSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India.ORCID 0000-0002-8314-0425
Madhuri GirdharSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India.
Raj KumarDepartment of Pharmaceutical Sciences, University of Michigan, Ann Arbor, MI 48105, USA.ORCID 0000-0002-5497-9678
Harshil S ChaturvediSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India.
Agrataben VadhelSchool of Bioengineering and Biosciences, Lovely Professional University, Phagwara 144411, India.ORCID 0000-0002-0180-3628
Pratima R SolankiSpecial Center for Nanoscience, Jawaharlal Nehru University, New Delhi 110067, India.
Anil KumarGene Regulation Laboratory, National Institute of Immunology, New Delhi 110067, India.
Deepak KumarSchool of Chemical Engineering and Physical Sciences, Lovely Professional University, Phagwara 144411, India.
Narsimha MamidiDepartment of Chemistry and Nanotechnology, School of Engineering and Science, Tecnologico de Monterrey, Monterrey 64849, Mexico.ORCID 0000-0001-8842-4649
Lovely Professional University · INJawaharlal Nehru University · INNational Institute of Immunology · INTecnológico de Monterrey · MXUniversity of Michigan · US

Funding

Lovely Professional University LPU/DRD/IPS/Sac/002.
6 · The paper itself

Abstract

Bone-related diseases have been increasing worldwide, and several nanocomposites have been used to treat them. Among several nanocomposites, polyhydroxybutyrate (PHB)-based nanocomposites are widely used in drug delivery and tissue engineering due to their excellent biocompatibility and biodegradability. However, PHB use in bone tissue engineering is limited due to its inadequate physicochemical and mechanical properties. In the present work, we synthesized PHB-based nanocomposites using a nanoblend and nano-clay with modified montmorillonite (MMT) as a filler. MMT was modified using trimethyl stearyl ammonium (TMSA). Nanoblend and nano-clay were fabricated using the solvent-casting technique. Inspection of the composite structure revealed that the basal spacing of the polymeric matrix material was significantly altered depending on the loading percentage of organically modified montmorillonite (OMMT) nano-clay. The PHB/OMMT nanocomposite displayed enhanced thermal stability and upper working temperature upon heating as compared to the pristine polymer. The dispersed (OMMT) nano-clay assisted in the formation of pores on the surface of the polymer. The pore size was proportional to the weight percentage of OMMT. Further morphological analysis of these blends was carried out through FESEM. The obtained nanocomposites exhibited augmented properties over neat PHB and could have an abundance of applications in the industry and medicinal sectors. In particular, improved porosity, non-immunogenic nature, and strong biocompatibility suggest their effective application in bone tissue engineering. Thus, PHB/OMMT nanocomposites are a promising candidate for 3D organ printing, lab-on-a-chip scaffold engineering, and bone tissue engineering.

Indexed as

biomedical technologymontmorillonitenanoblendnano-claynanocompositepolyhydroxy butyratetissue engineering

Identifiers

PMID34832945
PMCPMC8622693
OpenAlexW3213421536

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.